Medicus Pharma Ltd. announced promising interim results from its SKNJCT-003 Phase 2 clinical study aimed at the non-invasive treatment of basal cell carcinoma (BCC) using the investigational product D ...
Add Yahoo as a preferred source to see more of our stories on Google. Skin cancer is the most common type of cancer in the United States with 5.4 million new cases of the disease reported every year.
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...
A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...
Reston, VA (August 21, 2025)--A topical fluorescent molecular contrast agent, PARPi-FL, can detect basal cell carcinoma through intact skin in as little as five minutes in ex vivo human tissues, ...
Skin cancer is the most common type of cancer in the United States with 5.4 million new cases of the disease reported every year. TODAY contributor and New Beauty editor-at-large Sarah Eggenberger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results